See what happened at SABCS 2023  Learn more

Browse, watch, read, and learn more.

Helpful information for patients with invasive breast cancer.

FAQs

“Like many cancer patients, I was overwhelmed at the beginning of my cancer journey. Now that I’ve gone through my journey, I’m passionate about helping breast cancer patients make informed treatment decisions.”

Punita K., breast cancer survivor and Oncotype DX® Ambassador

Recurrence Score result: 6

Videos

85%
of Breast Recurrence Score test patients have $0 financial responsibility*

This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Patient cost-sharing amounts, including deductibles and copays, will vary by plan and coverage type. Only your insurer can confirm if and how Breast Recurrence Score test will be covered.

90%
of Breast Recurrence Score test patients have a financial responsibility of <$100*

This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Patients with high-deductible plans may receive a bill for most or all the cost of the Breast Recurrence Score test if they have not satisfied their deductible.

* Testing performed at an Exact Sciences clinical lab in Redwood City, CA (Genomic Health, Inc.).

† The numbers cited are based on historical patient billing data from 1/2/2021 to 12/31/2021. Rates of coverage vary by state and region. Exceptions for coverage may apply. Exact Sciences strongly encourages you to contact your insurer with questions about Oncotype DX Breast Recurrence Score test coverage.